Phase II Trial of Low Dose, Subcutaneous Decitabine in MyelofibrosisOlatoyosi Odenike, Wendy Stock, John E. Godwin et al.|Blood|2008Cited by 32
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Jason W. Van Winkle, Robin Dewar et al.|The Journal of Infectious Diseases|2024Cited by 13